Similarly, contradictory results were obtained for growth hormone (GH), and some initial studies reported increased somatotropic activity associated with the severity of HD [71], while other studies do not confirm this relationship, showing no differences in GH levels in HD patients compared to controls [71,141,142]. This evidence concerns the gene GH1 and Huntington disease.